|Bid||56.72 x 28400|
|Ask||56.74 x 2100|
|Day's Range||55.88 - 57.03|
|52 Week Range||43.90 - 67.99|
|Beta (5Y Monthly)||1.12|
|PE Ratio (TTM)||25.31|
|Earnings Date||Aug 04, 2022|
|Forward Dividend & Yield||2.00 (3.49%)|
|Ex-Dividend Date||May 02, 2022|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for BAYN.DE
View additional multimedia and more ESG storytelling from Bayer on 3blmedia.com
Every plate of food is the center of a story.
The U.S. Supreme Court on Monday rejected another Bayer AG bid to dismiss litigation alleging that its Roundup weedkiller causes cancer as the German pharmaceutical and chemical giant tries to avoid potentially billions of dollars in damages. The justices turned away a Bayer appeal and left in place a lower court decision upholding an $87 million judgment awarded in a lawsuit in California to Alberta and Alva Pilliod, who were diagnosed with cancer after spraying Roundup for more than three decades. The Supreme Court on June 21 rejected a Bayer appeal in a different Roundup case.